Patent application number | Description | Published |
20110091329 | Pumping System with Two Way Communication - A pumping system for moving water of a swimming pool includes a water pump, a variable speed motor, and an arrangement for controlling the variable speed motor. The pumping system further includes an auxiliary device operably connected to the arrangement for controlling, and an arrangement for providing two-way communication between the arrangement for controlling and the auxiliary device. The arrangement for controlling is capable of receiving a parameter from the auxiliary device through the arrangement for providing two-way communication. In one example, the arrangement for controlling is capable of independently controlling the variable speed motor without receipt of a parameter from the auxiliary device. In addition or alternatively, the arrangement for controlling is operable to selectively alter operation of the motor based upon the parameter. In addition or alternatively, the arrangement for controlling is configured to optimize a power consumption of the variable speed motor over time based upon the parameters received. A method for controlling the pumping system is also provided. | 04-21-2011 |
20120063921 | Control Algorithm of Variable Speed Pumping System - A pumping system includes a pump for moving water. In one aspect, this is in connection with performance of an operation. The system includes a variable speed motor operatively connected to drive the pump. A value indicative of flow rate of water is determined and the motor is controlled to adjust the flow rate indicative value toward a constant. A value indicative of flow pressure is determined and the motor is controlled to adjust the flow pressure indicative value toward a constant. A selection is made between flow rate control and flow pressure control. In another aspect, the pump is controlled to perform a first operation, and is operated to perform a second water operation. Control of operation of the pump to perform the first water operation is altered in response to operation of the pump to perform the second operation. | 03-15-2012 |
20120100010 | Speed Control - Embodiments of the invention provide a pumping system for at least one aquatic application controlled by a user. The pumping system includes a pump, a variable speed motor, a memory, and a controller. The pumping system includes a user interface with a first speed button, a second speed button, an increase button, and a decrease button. The buttons provide an actuate and release operation, a first touch and hold operation, and a second touch and hold operation. The controller operates the variable speed motor at a substantially constant speed based on a current speed value selected by the user using the buttons. | 04-26-2012 |
20120145251 | Discharge Vacuum Relief Valve for Safety Vacuum Release System - Embodiments of the invention provide a pumping system and a discharge vacuum relief valve for use in a hydraulic system including a safety vacuum release system pump to circulate water in a swimming pool and/or a spa. The hydraulic system includes one or more check valves located on a discharge side of the safety vacuum release system pump. The discharge vacuum relief valve is capable of venting a vacuum at the discharge side of the safety vacuum release system pump during a vacuum event at a suction side of the safety vacuum release system pump. | 06-14-2012 |
20130129536 | Flow Locking System and Method - Embodiments of the invention provide a pumping system and method including a flow locking feature. A pump controller includes a user interface configured to initially receive and set a plurality of programmed flow rate settings, a maximum locked flow rate, and a minimum locked flow rate. The pump controller is also configured to disable resetting of the maximum flow rate and the minimum flow rate once they are initially received and set and to allow resetting of the plurality of programmed flow rate settings throughout operation of the pumping system. The pump controller is further configured to operate a pump motor in order to maintain a first flow rate set by one of the plurality of programmed flow rate settings as long as the first flow rate is between the minimum locked flow rate and the maximum locked flow rate. | 05-23-2013 |
20130251542 | Speed Control - A pumping system for moving water of a swimming pool includes a water pump, an infinitely variable speed motor, and an arrangement for operating the motor. In one example, the pumping system includes a memory configured to store a plurality of retained speed values, an arrangement for providing a plurality of retained speed values to the memory, and an arrangement for reading a selected one of the plurality of retained speed values from the memory. In addition or alternatively, the pumping system includes a storage medium for digitally storing a plurality of pre-established motor speed values and an arrangement for receiving input from a user to select one of the pre-established motor speeds. In addition or alternatively, the pumping system further includes an arrangement for restarting operation of the motor at a previously selected speed value when power supplied to the motor is interrupted during operation of the motor. A method for controlling the pumping system is also provided. | 09-26-2013 |
20140322030 | Control Algorithm of Variable Speed Pumping System - A pumping system includes a pump for moving water. In one aspect, this is in connection with performance of an operation. The system includes a variable speed motor operatively connected to drive the pump. A value indicative of flow rate of water is determined and the motor is controlled to adjust the flow rate indicative value toward a constant. A value indicative of flow pressure is determined and the motor is controlled to adjust the flow pressure indicative value toward a constant. A selection is made between flow rate control and flow pressure control. In another aspect, the pump is controlled to perform a first operation, and is operated to perform a second water operation. Control of operation of the pump to perform the first water operation is altered in response to operation of the pump to perform the second operation. | 10-30-2014 |
20150030463 | Pumping System with Two Way Communication - A pumping system for moving water of a swimming pool includes a water pump, a variable speed motor, and an arrangement for controlling the variable speed motor. The pumping system further includes an auxiliary device operably connected to the arrangement for controlling, and an arrangement for providing two-way communication between the arrangement for controlling and the auxiliary device. The arrangement for controlling is capable of receiving a parameter from the auxiliary device through the arrangement for providing two-way communication. In one example, the arrangement for controlling is capable of independently controlling the variable speed motor without receipt of a parameter from the auxiliary device. In addition or alternatively, the arrangement for controlling is operable to selectively alter operation of the motor based upon the parameter. In addition or alternatively, the arrangement for controlling is configured to optimize a power consumption of the variable speed motor over time based upon the parameters received. A method for controlling the pumping system is also provided. | 01-29-2015 |
20150204334 | Speed Control - In some embodiments, a pumping system for at least one aquatic application controlled by a user is disclosed. The pumping system includes a pump and a motor disposed in a first housing and coupled to the pump. A user interface is associated with a second housing, the second housing defined by a base portion shaped to interact with the first housing and a user interface portion that carries a plurality of control buttons, wherein the second housing is selectively positionable among a plurality of positions relative to the first housing. | 07-23-2015 |
20150211531 | Speed Control - A pumping system for moving water of a swimming pool includes a water pump, an infinitely variable speed motor, and an arrangement for operating the motor. In one example, the pumping system includes a memory configured to store a plurality of retained speed values, an arrangement for providing a plurality of retained speed values to the memory, and an arrangement for reading a selected one of the plurality of retained speed values from the memory. In addition or alternatively, the pumping system includes a storage medium for digitally storing a plurality of pre-established motor speed values and an arrangement for receiving input from a user to select one of the pre-established motor speeds. In addition or alternatively, the pumping system further includes an arrangement for restarting operation of the motor at a previously selected speed value when power supplied to the motor is interrupted during operation of the motor. A method for controlling the pumping system is also provided. | 07-30-2015 |
Patent application number | Description | Published |
20080300265 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever and Crimean-Congo hemorrhagic fever). | 12-04-2008 |
20090036513 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 02-05-2009 |
20100189685 | Antiviral Drugs for Treatment or Prevention of Dengue Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 07-29-2010 |
20110027227 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family is disclosed. | 02-03-2011 |
20110064693 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 03-17-2011 |
20110118505 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pinchinde, and VSV), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 05-19-2011 |
20110172281 | Anti-Viral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 07-14-2011 |
20110236434 | Polymorphic Forms of ST-246 and Methods of Preparation - Polymorph forms of 4-trifluoromethyl-N-(3,3 | 09-29-2011 |
20120022027 | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to Arenaviridae (Junin, Machupo, Guanavito, Sabia and Lassa), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 01-26-2012 |
20120022046 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections - Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 01-26-2012 |
20120071447 | Antiviral Drugs for Treatment of Arenavirus Infection - Methods, compounds, and pharmaceutical compositions for treating an arenavirus infections are disclosed. Methods for preparing the compounds and pharmaceutical compositions are also disclosed. | 03-22-2012 |
20120107276 | Anti-Arenaviral Compounds - Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by hemorrhagic fever viruses, such as Arenaviruses. | 05-03-2012 |
20120149751 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 06-14-2012 |
20120258079 | Treatment and Prevention of Dengue Virus Infections - Methods and pharmaceutical compositions for treating viral infections, by administering certain | 10-11-2012 |
20120308519 | Anti-Arenaviral Compounds - Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by hemorrhagic fever viruses, such as Arenaviruses. | 12-06-2012 |
20130129677 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections - Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 05-23-2013 |
20130165493 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 06-27-2013 |
20130195796 | Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens - Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed. | 08-01-2013 |
20130261087 | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENA VIRUSES - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pinchinde, and VSV), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 10-03-2013 |
20130303491 | Antiviral Drugs for Treatement or Prevention of Dengue Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 11-14-2013 |
20140011854 | ST-246 Liquid Formulations and Methods - The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation. | 01-09-2014 |
20140100245 | Antiviral Drugs for Treatment of Arenvirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the | 04-10-2014 |
20140128426 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the | 05-08-2014 |
20140243367 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 08-28-2014 |
20140301979 | ANTI-ARENAVIRAL COMPOUNDS - Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by hemorrhagic fever viruses, such as Arenaviruses. | 10-09-2014 |
20140378681 | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS,PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to Arenaviridae (Junin, Machupo, Guanavito, Sabia and Lassa), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 12-25-2014 |
20150023916 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 01-22-2015 |
20150202195 | SMALL MOLECULE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DENGUE VIRUS INFECTION - Methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivinis is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 07-23-2015 |
20160081950 | INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS - Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed. | 03-24-2016 |
20160082128 | ST-246 LIQUID FORMULATIONS AND METHODS - The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation. | 03-24-2016 |